No evident disease activity (NEDA) in the AFFIRM study: association with brain atrophy and functional outcomes
نویسندگان
چکیده
No evident disease activity (NEDA) in the AFFIRM study: association with brain atrophy and functional outcomes R. Rudick1, E. Fisher2, A. Goodman3, J.T. Phillips4, A. Pace5, S. Belachew5 1Mellen Center for Multiple Sclerosis Treatment and Research, 2Department of Biomedical Engineering, Cleveland Clinic Foundation, Cleveland, OH, 3University of Rochester, Rochester, NY, 4Multiple Sclerosis Program, Baylor Institute for Immunology Research, Dallas, TX, 5Biogen Idec Inc., Cambridge, MA, United States
منابع مشابه
“No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
Using combined endpoints to define no evident disease activity (NEDA) is becoming increasingly common when setting targets for treatment outcomes in multiple sclerosis (MS). Historically, NEDA has taken account of the occurrence of relapses, brain magnetic resonance imaging (MRI) lesions and disability worsening, but this approach places emphasis on inflammatory activity in the brain and mostly...
متن کاملHippocampal Atrophy Studying in Alzheimer's Disease Diagnosis Using Brain MRI Images
Background and Aim: For effective treatment of Alzheimer's disease (AD), it is important to accurately diagnosis of AD and its earlier stage, Mild Cognitive Impairment (MCI). One of the most important approaches of early detection of AD is to measure atrophy, which uses various kinds of brain scans, such as MRI. The main objective of the current research was to provide a computerized diagnostic...
متن کاملCorrelation of MRI findings and cognitive function in multiple sclerosis patients using montreal cognitive assessment test
Background: Magnetic resonance imaging (MRI) has improved the diagnosis and management of patients with multiple sclerosis (MS). Montreal Cognitive Assessment (MoCA) is a brief, sensitive test that has been recommended by National Institute of Neurological Diseases and Stroke and Canadian Stroke Network (NINDS-CSN) as a reliable tool to detect mild cognitive impairments. This study aimed to eva...
متن کاملThe Determiners of Temporal Lobe Epilepsy Surgery Outcome in a Developing Country
Background: Epilepsy surgery has become a successful treatment option for patients with drug-resistant epilepsies. Objectives: This study aimed to assess temporal lobe epilepsy (TLE) surgery outcome and its association with epilepsy duration, the presence of pre-surgical generalized tonic-clonic seizure (GTCS), and brain MRI findings. Materials & Methods: This retrospective study was perfo...
متن کاملAssessing ‘No Evidence of Disease Activity’ Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study
BACKGROUND 'No evidence of disease activity' (NEDA), a composite measure of clinical and magnetic resonance imaging outcomes, provides a comprehensive assessment of disease activity, but is not extensively reported in clinical practice. NEDA-3 is defined as patients with no new/enlarged T2 or gadolinium-enhancing lesions, no relapses, and no disability progression (according to Expanded Disabil...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014